Has Dharam Mann, MD received payments from drug or device companies?

Yes. Drug and device makers reported $15,113 in general payments to Dharam Mann, MD across 171 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dharam Mann, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dharam Mann, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dharam Mann, MD

Interventional Pain Management · Whiting, NJNPI 1063463099

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $10,090 of the $15,113 with a category attached, or 66.8%. Foundation Fusion Solutions, LLC accounts for 66.8% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $11,258 and has fallen 96.4% since, to $404 in 2025.

$15,113in general payments, 2019–2025

Across 171 payments — averaging $88.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Foundation Fusion Solutions, LLC$10K
Abbott$2K
Medtronic$1K
Boston Scientific$297
Vertiflex, Inc.$238
Stimwave Technologies Incorporated$220
plus $995 from 9 others

$1,150in research payments, 2019–2025

Across 7 payments — averaging $164.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vertiflex, Inc.$1K

$1,947,116in ownership & investment interests, 2019–2025

Across 7 payments — averaging $278,159 each. An ownership or investment interest held by the physician or an immediate family member.

SPR Therapeutics, Inc$1.9M

What the payments were for

Food & beverage$5,02333%
Ownership interest$10,09067%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Foundation Fusion Solutions, LLC	1	$10,090
Abbott	115	$1,962
Medtronic(2 entities)	26	$1,311
Boston Scientific	8	$297
Vertiflex, Inc.	4	$238
Stimwave Technologies Incorporated	2	$220
Axonics, Inc.	2	$196
Olympus America Inc.	2	$177
Vertos Medical, Inc.	4	$140
Relievant Medsystems, Inc.	2	$120
Painteq LLC	1	$116
Procept Biorobotics Corporation	1	$99
Globus Medical	1	$69
Spinefrontier, Inc.	1	$63
Linus Health, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional pain management providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$1,193,509

Medicare patients

1,129

Services billed

52,081

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OxycontinOxycodone Hcl	26	$12,231
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	431	$9,856
Lidocaine	28	$4,655
Gabapentin	298	$4,043
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	144	$3,536
Pregabalin	73	$2,428
Oxycodone Hcl	124	$1,976
Morphine Sulfate ErMorphine Sulfate	37	$1,471
Tramadol Hcl	256	$1,451
Diclofenac Sodium	26	$1,418
Clonidine	13	$1,359
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine	11	$1,160
Morphine Sulfate	38	$1,068
Tizanidine Hcl	44	$649
Cyclobenzaprine Hcl	38	$623

Paid to pharmacies, not to this prescriber.

Other interventional pain management in Whiting

Sanjiv ParikhRutherford$5K
Anil SharmaShrewsbury$1K
Moises KaweblumLakewood$0

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →